ISIN | CH0113817065 |
---|---|
Valor Number | 11381706 |
Bloomberg Global ID | BBG0017T9CP3 |
Fund Name | Bellevue Biotech AA CHF |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 3,131.91 CHF | 10.07.2025 |
---|---|---|
Previous Price * | 3,097.80 CHF | 09.07.2025 |
52 Week High * | 3,593.23 CHF | 16.07.2024 |
52 Week Low * | 2,772.30 CHF | 10.04.2025 |
NAV * | 3,131.91 CHF | 10.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 22,733,840 | |
Unit/Share Assets *** | 10,274,483 | |
Trading Information SIX |
YTD Performance | -5.21% |
31.12.2024 - 10.07.2025
31.12.2024 10.07.2025 |
---|---|---|
1 month | +0.33% |
10.06.2025 - 10.07.2025
10.06.2025 10.07.2025 |
3 months | +12.97% |
10.04.2025 - 10.07.2025
10.04.2025 10.07.2025 |
6 months | -5.61% |
10.01.2025 - 10.07.2025
10.01.2025 10.07.2025 |
1 year | -9.34% |
10.07.2024 - 10.07.2025
10.07.2024 10.07.2025 |
2 years | +0.93% |
10.07.2023 - 10.07.2025
10.07.2023 10.07.2025 |
3 years | -10.03% |
11.07.2022 - 10.07.2025
11.07.2022 10.07.2025 |
5 years | -12.53% |
10.07.2020 - 10.07.2025
10.07.2020 10.07.2025 |
Equity Participation Rate in % | 82.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 11.6387 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 10.07.2025 |
Gilead Sciences Inc | 9.65% | |
---|---|---|
Amgen Inc | 8.86% | |
Vertex Pharmaceuticals Inc | 8.47% | |
AstraZeneca PLC ADR | 5.48% | |
Regeneron Pharmaceuticals Inc | 5.30% | |
Alnylam Pharmaceuticals Inc | 4.86% | |
argenx SE ADR | 3.18% | |
Verona Pharma PLC ADR | 2.88% | |
BeOne Medicines Ltd ADR | 2.68% | |
Rhythm Pharmaceuticals Inc | 1.96% | |
Last data update | 31.05.2025 |
TER | 1.82% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 2.00% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |